Phase 1 4 trials
Phase 1
NCT06969612 May 2025 → May 2027 expected non-small cell lung carcinoma Peking University Cancer Hospital & Institute
Recruiting
No outcome recorded
Phase 1
NCT05486949 Jul → Oct 2022 —
Dizal Pharmaceuticals
Completed
No outcome recorded
Phase 1
NCT04225208 Jan → Mar 2020 —
Dizal Pharmaceuticals
Completed
No outcome recorded
Phase 1
NCT03728023 Nov 2018 → Aug 2019 —
Dizal Pharmaceuticals
Completed
No outcome recorded
Phase 1/2 16 trials
Phase 1/2
NCT07706959 Jul 2026 → Jan 2028 expected peripheral T-cell lymphoma, not otherwise specified Ruijin Hospital
Not yet recruiting
No outcome recorded
Phase 1/2
NCT07496229 Apr 2026 → Sep 2029 expected T-cell non-Hodgkin lymphoma Dizal Pharmaceuticals
Recruiting
No outcome recorded
Phase 1/2
NCT07525466 Apr 2026 → Mar 2028 expected extranodal nasal NK/T cell lymphoma , secondary hemophagocytic lymphohistiocytosis Beijing Tongren Hospital
Recruiting
No outcome recorded
Phase 1/2
NCT07493330 Mar 2026 → Dec 2029 expected refractory malignant neoplasm Ruijin Hospital
Not yet recruiting
No outcome recorded
Phase 1/2
NCT07339527 Jan 2026 → Jan 2028 expected mature T-cell and NK-cell non-Hodgkin lymphoma Sun Yat-sen University
Not yet recruiting
No outcome recorded
Phase 1/2
NCT07297550 Dec 2025 → Dec 2026 expected aplastic anemia Institute of Hematology & Blood Diseases Hospital, China
Not yet recruiting
No outcome recorded
Phase 1/2
NCT07196163 Oct 2025 → Oct 2028 expected autoimmune thrombocytopenia Peking University People's Hospital
Not yet recruiting
No outcome recorded
Phase 1/2
NCT07209163 Oct 2025 → Mar 2026 overdue peripheral T-cell lymphoma, not otherwise specified Ruijin Hospital
Not yet recruiting
No outcome recorded
Phase 1/2
NCT07093710 Aug 2025 → Aug 2027 expected peripheral T-cell lymphoma, not otherwise specified Sun Yat-sen University
Recruiting
No outcome recorded
Phase 1/2
NCT06966154 May 2025 → May 2027 expected T-cell and NK-cell neoplasm , extranodal nasal NK/T cell lymphoma Fudan University
Recruiting
No outcome recorded
Phase 1/2
NCT06855823 Jan 2025 → Dec 2026 expected peripheral T-cell lymphoma, not otherwise specified Sun Yat-sen University
Recruiting
No outcome recorded
Phase 1/2
NCT06757387 Dec 2024 → Dec 2028 expected peripheral T-cell lymphoma, not otherwise specified Peking University Cancer Hospital & Institute
Not yet recruiting
No outcome recorded
Phase 1/2
NCT06690671 Dec 2024 → Jun 2025 overdue non-small cell lung carcinoma Shanghai Chest Hospital
Not yet recruiting
No outcome recorded
Phase 1/2
NCT06739265 Sep 2024 → Sep 2026 expected peripheral T-cell lymphoma, not otherwise specified Peking Union Medical College Hospital
Recruiting
No outcome recorded
Phase 1/2
NCT04105010 Sep 2019 → Oct 2023 peripheral T-cell lymphoma, not otherwise specified Dizal Pharmaceuticals
Completed
No outcome recorded
Phase 1/2
NCT03450330 Apr 2018 → Sep 2019 non-small cell lung carcinoma Dizal Pharmaceuticals
Completed
No outcome recorded
Show 6 more trials Phase 2 18 trials
Phase 2
NCT07682792 Sep 2026 → Jan 2030 expected T-cell large granular lymphocyte leukemia , mycosis fungoides and variants Washington University School of Medicine
Not yet recruiting
No outcome recorded
Phase 2
NCT07380984 Mar 2026 → Feb 2029 expected mature T-cell and NK-cell non-Hodgkin lymphoma Ruijin Hospital
Recruiting
No outcome recorded
Phase 2
NCT07457177 Feb 2026 → Jan 2028 expected extranodal nasal NK/T cell lymphoma LIANG WANG
Not yet recruiting
No outcome recorded
Phase 2
NCT07303881 Feb 2026 → Jun 2027 expected hematologic disorder , lung cancer The First Affiliated Hospital of Guangzhou Medical University
Not yet recruiting
No outcome recorded
Phase 2
NCT07385989 Jan 2026 → Dec 2028 expected mature T-cell and NK-cell non-Hodgkin lymphoma Wei Xu
Not yet recruiting
No outcome recorded
Phase 2
NCT07279584 Dec 2025 → Dec 2026 expected peripheral T-cell lymphoma, not otherwise specified Ruijin Hospital
Not yet recruiting
No outcome recorded
Phase 2
NCT07110103 Oct 2025 → Mar 2027 expected small cell lung carcinoma Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Recruiting
No outcome recorded
Phase 2
NCT07081607 Jul 2025 → Jul 2026 overdue peripheral T-cell lymphoma, not otherwise specified Ruijin Hospital
Not yet recruiting
No outcome recorded
Phase 2
NCT07032532 Jul 2025 → Dec 2028 expected peripheral T-cell lymphoma, not otherwise specified Sun Yat-sen University
Not yet recruiting
No outcome recorded
Phase 2
NCT06630091 Feb 2025 → Jul 2027 expected peripheral T-cell lymphoma, not otherwise specified M.D. Anderson Cancer Center
Recruiting
No outcome recorded
Phase 2
NCT06701344 Dec 2024 → May 2026 overdue enteropathy-associated T-cell lymphoma Ruijin Hospital
Not yet recruiting
No outcome recorded
Phase 2
NCT06573138 Sep 2024 → Jul 2027 expected extranodal nasal NK/T cell lymphoma Ruijin Hospital
Not yet recruiting
No outcome recorded
Phase 2
NCT06733051 Jan 2024 → Dec 2026 expected mature T-cell and NK-cell non-Hodgkin lymphoma Sun Yat-sen University
Recruiting
No outcome recorded
Phase 2
NCT06198907 Jan 2024 → Dec 2026 expected non-small cell lung carcinoma Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Not yet recruiting
No outcome recorded
Phase 2
NCT05963347 Aug 2023 → Jul 2025 overdue peripheral T-cell lymphoma, not otherwise specified Henan Cancer Hospital
Recruiting
No outcome recorded
Phase 2
NCT06295432 Jun 2023 → Dec 2026 expected non-small cell lung carcinoma Dizal Pharmaceuticals
Recruiting
No outcome recorded
Phase 2
NCT06511895 May 2022 → Oct 2025 peripheral T-cell lymphoma, not otherwise specified Dizal Pharmaceuticals
Completed
No outcome recorded
Phase 2
NCT06511869 Mar 2022 → Mar 2025 peripheral T-cell lymphoma, not otherwise specified Dizal Pharmaceuticals
Completed
No outcome recorded
Show 8 more trials Phase 2/3 2 trials
Phase 2/3
NCT07369739 Jan 2026 → Jan 2027 expected Epstein-Barr virus infection , histiocytosis Beijing Friendship Hospital
Recruiting
No outcome recorded
Phase 2/3
NCT07339345 Jun 2025 → Jun 2026 overdue hemophagocytic syndrome Beijing Friendship Hospital
Recruiting
No outcome recorded
Phase 3 4 trials
Phase 3
NCT07639879 Jul 2026 → Jul 2029 expected mature T-cell and NK-cell non-Hodgkin lymphoma Tarapeutics Science Inc.
Not yet recruiting
No outcome recorded
Phase 3
NCT07300514 Mar 2026 → Dec 2028 expected —
Fudan University
Recruiting
No outcome recorded
Phase 3
NCT07414758 Feb 2026 → Sep 2028 expected peripheral T-cell lymphoma, not otherwise specified Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Recruiting
No outcome recorded
Phase 3
NCT07234162 May 2024 → Nov 2027 expected peripheral T-cell lymphoma, not otherwise specified Dizal Pharmaceuticals
Recruiting
No outcome recorded